Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Rare cancers and tumour agnostic oncology

Towards an agnostic medical taxonomy?


20 Mar 2023


Rare cancers and tumour agnostic oncology


Targeted Therapy;  Molecular Oncology;  Genetic and Genomic Testing;  Immunotherapy;  Rare Cancers;  Cancer Research

Tumour Site


Christoph Benedikt Westphalen


C.B. Westphalen

Author affiliations

  • Medical Oncology Department, LMU Klinikum der Universität München, 81377 - Munich/DE


This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.